Casdin Capital as of March 31, 2022
Portfolio Holdings for Casdin Capital
Casdin Capital holds 47 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biolife Solutions Com New (BLFS) | 7.7 | $172M | 7.6M | 22.73 | |
| Alnylam Pharmaceuticals (ALNY) | 7.3 | $163M | 1.0M | 163.29 | |
| Eqrx | 7.3 | $163M | 40M | 4.13 | |
| Fate Therapeutics (FATE) | 5.9 | $132M | 3.4M | 38.77 | |
| Relay Therapeutics (RLAY) | 5.2 | $115M | 3.9M | 29.93 | |
| Somalogic Class A Com | 4.5 | $99M | 12M | 8.02 | |
| Blueprint Medicines (BPMC) | 4.4 | $99M | 1.6M | 63.88 | |
| Maxcyte (MXCT) | 4.4 | $98M | 14M | 6.99 | |
| Invitae (NVTAQ) | 4.4 | $97M | 12M | 7.97 | |
| EXACT Sciences Corporation (EXAS) | 4.2 | $93M | 1.3M | 69.92 | |
| Pacific Biosciences of California (PACB) | 3.3 | $73M | 8.0M | 9.10 | |
| Verve Therapeutics (VERV) | 3.2 | $72M | 3.1M | 22.82 | |
| Absci Corp (ABSI) | 2.9 | $65M | 7.7M | 8.43 | |
| Sarepta Therapeutics (SRPT) | 2.8 | $63M | 800k | 78.12 | |
| Agios Pharmaceuticals (AGIO) | 2.7 | $61M | 2.1M | 29.11 | |
| Revolution Medicines (RVMD) | 2.7 | $61M | 2.4M | 25.51 | |
| Denali Therapeutics (DNLI) | 2.2 | $48M | 1.5M | 32.17 | |
| Beam Therapeutics (BEAM) | 2.1 | $47M | 819k | 57.30 | |
| Global Blood Therapeutics In | 2.1 | $46M | 1.3M | 34.64 | |
| Twist Bioscience Corp (TWST) | 1.9 | $44M | 880k | 49.38 | |
| Caredx (CDNA) | 1.9 | $43M | 1.2M | 36.99 | |
| Tenaya Therapeutics (TNYA) | 1.9 | $42M | 3.6M | 11.78 | |
| Tango Therapeutics (TNGX) | 1.9 | $42M | 5.5M | 7.58 | |
| Century Therapeutics (IPSC) | 1.8 | $40M | 3.2M | 12.59 | |
| Beigene Sponsored Adr (ONC) | 1.3 | $28M | 150k | 188.60 | |
| Guardant Health (GH) | 1.2 | $28M | 420k | 66.24 | |
| Dermtech Ord ord (DMTKQ) | 1.1 | $26M | 1.7M | 14.68 | |
| Ginkgo Bioworks Holdings Cl A Shs | 0.8 | $17M | 4.2M | 4.03 | |
| Sema4 Holdings Corp Com Cl A | 0.7 | $15M | 5.0M | 3.07 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.6 | $14M | 1.0M | 13.88 | |
| Monte Rosa Therapeutics (GLUE) | 0.6 | $14M | 961k | 14.02 | |
| Seer Com Cl A (SEER) | 0.5 | $12M | 800k | 15.24 | |
| 2seventy Bio | 0.5 | $11M | 615k | 17.06 | |
| Exscientia Ads (EXAI) | 0.5 | $10M | 714k | 14.40 | |
| Generation Bio | 0.4 | $9.7M | 1.3M | 7.34 | |
| Science 37 Holdings | 0.4 | $9.6M | 1.8M | 5.35 | |
| Singular Genomics Systems In | 0.4 | $9.1M | 1.4M | 6.31 | |
| Mirati Therapeutics | 0.4 | $8.4M | 103k | 82.22 | |
| 4d Molecular Therapeutics In (FDMT) | 0.4 | $8.4M | 556k | 15.12 | |
| Magenta Therapeutics | 0.4 | $8.0M | 2.8M | 2.90 | |
| Zai Lab Adr (ZLAB) | 0.3 | $6.6M | 150k | 43.98 | |
| Codexis (CDXS) | 0.3 | $6.2M | 300k | 20.62 | |
| Kronos Bio | 0.2 | $4.2M | 583k | 7.23 | |
| Recursion Pharmaceuticals In Cl A (RXRX) | 0.2 | $3.9M | 548k | 7.16 | |
| Oric Pharmaceuticals (ORIC) | 0.1 | $3.2M | 602k | 5.34 | |
| Decibel Therapeutics | 0.0 | $1.0M | 330k | 3.04 | |
| Lianbio Sponsored Ads (LIANY) | 0.0 | $766k | 206k | 3.71 |
